|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 279.80 GBX | +1.23% |
|
-1.13% | -22.28% |
| Dec. 05 | Bridgepoint Reportedly Mulls Takeover Offer for Advanced Medical Solutions Group | MT |
| Dec. 05 | Bridgepoint Reportedly Mulls Takeover Offer for Advanced Medical Solutions Group | MT |
| Capitalization | 2.31B 3.08B 2.64B 2.48B 4.26B 277B 4.64B 28.97B 11.19B 131B 11.54B 11.3B 478B | P/E ratio 2025 * |
18x | P/E ratio 2026 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise value | 2.78B 3.7B 3.18B 2.98B 5.13B 333B 5.58B 34.84B 13.45B 157B 13.88B 13.59B 575B | EV / Sales 2025 * |
4.94x | EV / Sales 2026 * | 4.33x |
| Free-Float |
79.85% | Yield 2025 * |
3.46% | Yield 2026 * | 3.73% |
Last Transcript: Bridgepoint Group plc
| 1 day | +1.23% | ||
| 1 week | -1.13% | ||
| Current month | -1.13% | ||
| 1 month | -5.85% | ||
| 3 months | -14.70% | ||
| 6 months | -4.77% | ||
| Current year | -22.28% |
| 1 week | 262.6 |  | 287.2 |
| 1 month | 261 | | 309.8 |
| Current year | 229.2 | | 410 |
| 1 year | 229.2 | | 410 |
| 3 years | 164.8 | | 410 |
| 5 years | 164.8 | | 571 |
| 10 years | 164.8 | | 571 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Hughes
CEO | Chief Executive Officer | 60 | 2023-09-30 |
Ruth Prior
DFI | Director of Finance/CFO | 58 | 2024-12-31 |
Jamie Lucas
COO | Chief Operating Officer | 36 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Hughes
BRD | Director/Board Member | 60 | 2023-09-30 |
Archibald Norman
BRD | Director/Board Member | 71 | 2021-06-24 |
Carolyn McCall
BRD | Director/Board Member | 64 | 2021-07-11 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.23% | -1.13% | -21.40% | +38.10% | 3.08B | |
| +1.79% | +0.86% | +0.70% | +36.39% | 41.03B | |
| +1.92% | +0.42% | -26.54% | +6.26% | 30.82B | |
| +1.07% | -0.84% | -38.93% | - | 17.46B | |
| +0.43% | +1.68% | -2.08% | +67.63% | 5.59B | |
| 0.00% | -0.64% | +23.95% | +74.44% | 4.47B | |
| +0.33% | -1.08% | +13.61% | -20.52% | 1.28B | |
| +1.45% | +0.48% | +13.39% | +16.17% | 1.16B | |
| 0.00% | +0.65% | -23.00% | - | 914M | |
| -1.11% | -2.73% | -7.93% | +154.29% | 850M | |
| Average | +0.71% | -0.40% | -6.82% | +46.60% | 10.66B | |
| Weighted average by Cap. | +1.49% | +0.30% | -13.45% | +29.89% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 562M 748M 643M 603M 1.04B 67.34B 1.13B 7.05B 2.72B 31.8B 2.81B 2.75B 116B | 625M 833M 716M 671M 1.16B 74.98B 1.26B 7.85B 3.03B 35.41B 3.13B 3.06B 129B |
| Net income | 158M 211M 181M 170M 292M 18.97B 318M 1.99B 767M 8.96B 791M 774M 32.77B | 227M 302M 260M 243M 419M 27.18B 455M 2.84B 1.1B 12.84B 1.13B 1.11B 46.94B |
| Net Debt | 468M 623M 536M 502M 864M 56.08B 940M 5.87B 2.27B 26.49B 2.34B 2.29B 96.85B | 397M 529M 454M 426M 733M 47.56B 797M 4.98B 1.92B 22.46B 1.98B 1.94B 82.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 279.80 p | +1.23% | 909,791 |
| 25-12-04 | 276.40 p | +1.69% | 799,216 |
| 25-12-03 | 271.80 p | -1.16% | 889,231 |
| 25-12-02 | 275.00 p | +0.29% | 1,091,538 |
| 25-12-01 | 274.20 p | -3.11% | 911,045 |
Delayed Quote London S.E., December 05, 2025 at 11:35 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- BPT Stock
Select your edition
All financial news and data tailored to specific country editions
